Oncology Institute (DFPH) Interest Expenses (2021 - 2026)

Oncology Institute (DFPH) has 6 years of Interest Expenses data on file, last reported at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 65.28% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (down 31.05% YoY), and the FY2025 full-year result was $11.3 million, up 50.43% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.9 million, up from $1.9 million in the prior quarter.
• Across five years, Interest Expenses topped out at $5.6 million in Q1 2025 and bottomed at $61000.0 in Q2 2022.
• The 5-year median for Interest Expenses is $1.9 million (2025), against an average of $1.9 million.
• The widest annual swing landed in 2023, when Interest Expenses surged 2585.25%; it then sank 65.28% in 2026.
• A 5-year view of Interest Expenses shows it stood at $61000.0 in 2022, then soared by 3081.97% to $1.9 million in 2023, then slumped by 39.82% to $1.2 million in 2024, then soared by 64.04% to $1.9 million in 2025, then climbed by 0.94% to $1.9 million in 2026.
• The last three Interest Expenses figures came in at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.

Peer Comparison